Jonathan Poole

CIK 1604689 · CFO · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$42.4K

Companies

3

Total Filings

14

Lifetime Open-Market Net

-$271.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ACAD	Director	2,010	$21.09	$42.4K	$0	2	2026-06-01
EVLO	CFO	—	$0.00	—	$0	3	2020-01-30
GENOCEA BIOSCIENCES, INC. (GNCA) Delisted	Chief Financial Officer	39,247	$0.00	$24	-$271.5K	9	2018-02-12

Recent Filings · Page 2 of 2

14 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2016-05-10	GENOCEA BIOSCIENCES, INC. (GNCA) Delisted	Buy (P)	+4,000	$15.5K	EDGAR
2016-02-04	GENOCEA BIOSCIENCES, INC. (GNCA) Delisted	Grant (A)	—	$0	EDGAR
2015-03-02	GENOCEA BIOSCIENCES, INC. (GNCA) Delisted	Grant (A)	—	$0	EDGAR
2014-12-15	GENOCEA BIOSCIENCES, INC. (GNCA) Delisted	Grant (A)	—	$0	EDGAR

Showing 11–14 of 14

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.